Topic: Drug reform

CIA suggests feds appoint actuary to oversee potential pharmacare program

Staff | June 21, 2019 / News

Industry responds to expert panel’s pharmacare report

Staff | June 14, 2019 / News

How changing public coverage could affect the pharmaceuticals industry

Martha Porado | June 14, 2019 / News

Expert panel calling for single-payer pharmacare plan

Staff | June 13, 2019 / News

The potential effects of public drug plan changes on new therapies in Canada

Martha Porado | June 7, 2019 / News

B.C. government says expanding biosimilars will save nearly $100 million over three years

Alethea Spiridon | May 30, 2019 / News

Growing use of specialty drugs putting pressure on plan sponsors: report

Kelsey Rolfe | May 1, 2019 / News

Health Canada moving to simplify generic drug approval process

Kelsey Rolfe | April 17, 2019 / News

Head to head: Should Canada implement a national pharmacare program?

Benefits Canada | April 12, 2019 / News

Budget 2019: Feds to develop a strategy for high-cost drugs for rare diseases

Jennifer Paterson | March 20, 2019 / News